Peg-Interferon Alfa 2A (RO 25-8310)


Combined with:

Ribavirin

Indications and Reactions:

Role Indications Reactions
Primary
Hepatitis C 54.6%
Drug Use For Unknown Indication 8.3%
Hypertension 6.2%
Depression 4.2%
Thrombocytopenia 3.9%
Insomnia 3.8%
Rash 2.3%
Headache 2.2%
Nausea 2.0%
Anxiety 1.5%
Hepatitis B 1.5%
Asthma 1.4%
Pruritus 1.4%
Back Pain 1.3%
Myalgia 1.1%
Hiv Infection 1.0%
Prophylaxis 1.0%
Vitamin Supplementation 0.9%
Bipolar Disorder 0.8%
Hepatitis C Virus 0.8%
Syncope 14.9%
Vomiting 8.3%
Pneumonia 7.1%
Pyrexia 5.7%
Retinal Detachment 5.7%
Renal Failure Acute 5.4%
Weight Decreased 5.4%
White Blood Cell Count Decreased 5.1%
Death 4.5%
Transplant Rejection 4.5%
Convulsion 4.2%
Gastritis 4.2%
Cataract 3.6%
Ascites 3.3%
Deep Vein Thrombosis 3.3%
Vertigo 3.3%
Pancytopenia 3.0%
Pericardial Effusion 3.0%
Pericarditis 3.0%
Thrombocytopenia 3.0%
Secondary
Hepatitis C 42.3%
Drug Use For Unknown Indication 18.3%
Hypertension 5.3%
Depression 4.9%
Anxiety 4.7%
Thrombocytopenia 4.2%
Insomnia 3.8%
Nausea 2.8%
Myalgia 1.6%
Rash Generalised 1.4%
Supplementation Therapy 1.4%
Constipation 1.3%
Thrombosis Prophylaxis 1.3%
Agitation 1.1%
Asthma 1.1%
Vitamin Supplementation 1.1%
Immunosuppression 0.9%
Rash 0.9%
Back Pain 0.8%
Eczema 0.8%
Vomiting 15.3%
Pneumonia 8.4%
Syncope 7.4%
Pyrexia 7.0%
Retinal Detachment 5.6%
Transplant Rejection 5.6%
Hepatic Encephalopathy 4.7%
Thrombocytopenia 4.7%
Toxic Skin Eruption 4.7%
Pancytopenia 4.2%
Paranoia 4.2%
Renal Failure Acute 4.2%
Ileus 3.7%
Neutropenia 3.3%
Septic Shock 3.3%
Vision Blurred 3.3%
Pelvic Abscess 2.8%
Weight Decreased 2.8%
White Blood Cell Count Decreased 2.8%
Enteritis 2.3%

Drug Data